Online Course

2018 CARE MOC Session 2 - Lupus and Antiphospholipid Syndrome


Expires Sep 30, 2019

Program Information

CME: 4     MOC: 4

Assess your rheumatology medical knowledge and enhance your patient care. With 2018 CARE MOC Session 2 - Lupus and Antiphospholipid Syndrome you receive:

  • 12 case-based, multiple-choice questions with in-depth answer rationales
  • 4 AMA PRA Category 1 Credits™ and 4 ABIM MOC points with a passing score of 70% or higher

This online activity is for 2018 ACR/ARP Annual Meeting attendees only.

Target Audience
This course is designed for rheumatologists, physicians, healthcare providers who care for patients with rheumatic diseases, and those interested or engaged in rheumatology research.

Learning Objectives
Upon completion of this program, participants should be able to:

  • Implement an approach to management of patients with APS
  • Recognize and diagnose different clinical presentations of APS
  • Evaluate the risks and management of various aspects of pregnancy in women with SLE
  • Distinguish between manifestations of APS and acquired factor inhibitors in patients with SLE
  • Evaluate various therapeutic agents in the treatment of of different manifestations of SLE
  • Predict potential complications of treatment in patients with SLE

Registration Fees

Free for 2018 ACR/ARP Annual Meeting attendees.

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this online activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

MOC Statement
Successful completion of this CME activity enables the participant to earn up to 4 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Claim MOC Points
See instructions on how to claim MOC points

Faculty and Disclosures

ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

The faculty reported the following disclosures.

  • Moderator: Allan C. Gelber, MD, PhD, MPH - No relevant financial relationships to disclose
  • Speaker: Sarah Goglin, MD - No relevant financial relationships to disclose
  • Question Author: Megan Clowse, MD - GlaxoSmithCline2, UCB5
  • Question Author: Nina Ramessar, MD - No relevant financial relationships to disclose

Additional Program Information

2018 Annual Meeting Live Session: October 21, 12:30 PM - 2:00 PM
Moderator: Allan C. Gelber, MD, PhD, MPH - Johns Hopkins University
Speaker: Sarah Goglin, MD - University of California San Francisco
Question Author(s): Megan Clowse, MD - Duke University and Nina Ramessar, MD - Lakeland Rheumatology

About the Speaker
Dr. Goglin is a physician who specializes in rheumatology, with a clinical focus on lupus and the systemic vasculitides. She joined UCSF in 2009 and currently practices at the UCSF Rheumatology Faculty Practice, as well as in the Zuckerberg San Francisco General Rheumatology clinic. She also attends on the inpatient rheumatology consultation service at the Moffitt-Long Hospital. Presently, she is an Assistant Clinical Professor in the Division of Rheumatology and Department of Medicine.

Dr. Goglin is involved in many aspects of UCSF medical student, resident, and fellow education. She is the Co-Director for the Clinical Immersion Experiences (CIEx) and a coach in the Clinical Microsystems Clerkship in the UCSF School of Medicine. She lectures and leads small groups in the rheumatology section of the Pathogens and Host Defense course for first year medical students. She directs the rheumatology elective for fourth year medical student. Dr. Goglin supervises and teaches medical residents as they rotate through the rheumatology service at UCSF and ZSFG and directs the Rheumatology Intern half day and residency didactics. Dr. Goglin is closely involved in the education of rheumatology fellows through their clinical service at UCSF and ZSFG, and in lectures in their core didactics.

Contact Info / Inquiries
404-633-3777, ext. 381

© 2019 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us